Showing results (41-50 of 401) with videos related to
Sort By:
Pageof 41
Expert Review of Neurotherapeutics|August 28, 2014
Cognitive and behavioral problems in children with neurofibromatosis type 1: challenges and future directionsKatherine E Schwetye, David H GutmannGenes & Development|June 25, 2016
Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survivalLaura J Smithson, David H GutmannExpert Review of Anticancer Therapy|November 21, 2007
Cancer stem cells and brain tumors: uprooting the bad seedsDa Yong Lee, David H GutmannThe Lancet. Neurology|July 18, 2014
Neurofibromatosis type 1: a multidisciplinary approach to careAngela C Hirbe, David H GutmannNeuro-Oncology|May 22, 2019
Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microgliaXiaofan Guo, Yuan Pan, David H GutmannOncoimmunology|August 3, 2025
Pan-cancer single cell transcriptomic clustering reveals heterogeneous CD8+ exhausted T cell populations with different immune checkpoint inhibitor responsesRui Mu, Rasha Barakat, David H GutmannDevelopmental Cell|January 24, 2023
Neurons as stromal drivers of nervous system cancer formation and progressionCorina Anastasaki, Yunqing Gao, David H GutmannNature Neuroscience|December 30, 2015
The role of microglia and macrophages in glioma maintenance and progressionDolores Hambardzumyan, David H Gutmann, Helmut KettenmannOncotarget|May 27, 2017
KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growthCorina Anastasaki, Sonika Dahiya, David H GutmannPageof 41